Pharma News
3 mins ago
AZ agrees $2bn deal to buy radiopharma firm Fusion
AstraZeneca has upgraded a 2020 alliance with Fusion Pharma focusing on radioconjugate therapies for cancer,…
News
14 mins ago
Musk Comments on Women’s Health
Billionaire Elon Musk highlighted the potential link between hormonal birth control usage and increased risks…
Pharma News
55 mins ago
Traceability technologies tighten supply chain fakery
Image credit: Shutterstock/Arsgera Counterfeit drug production and distribution has increased in recent years. Disruption from…
News
1 hour ago
Musk Comments on Women’s Health
Billionaire Elon Musk highlighted the potential link between hormonal birth control usage and increased risks…
Health & Support
3 hours ago
Who Is Not A Good Candidate For Ketamine Therapy?
Nowadays, ketamine therapy has gained significant popularity for the treatment of mental health issues like…
Social illness
3 hours ago
Doctors working in paediatrics and anaesthetics at higher risk of suicidality, according to Australian survey
The recent COVID-19 pandemic exposed the stark reality of some of the challenges faced by…
Pharma News
3 hours ago
CST-2140 by CuraSen Therapeutics for Orthostatic Hypotension: Likelihood of Approval
CST-2140 is under clinical development by CuraSen Therapeutics and currently in Phase I for Orthostatic…
Pharma News
4 hours ago
Ulotaront hydrochloride by Sumitomo Pharma America for Schizophrenia: Likelihood of Approval
Ulotaront hydrochloride is under clinical development by Sumitomo Pharma America and currently in Phase III…
Pharma News
4 hours ago
Ulotaront hydrochloride by Sumitomo Pharma America for Generalized Anxiety Disorder (GAD): Likelihood of Approval
Ulotaront hydrochloride is under clinical development by Sumitomo Pharma America and currently in Phase III…
Pharma News
5 hours ago
Denosumab biosimilar by Sandoz Group for Bone Metastasis: Likelihood of Approval
Denosumab biosimilar is under clinical development by Sandoz Group and currently in Pre-Registration for Bone…